Journals / Turkish Journal of Endocrinology and Metabolism / 2020 / Cilt: 24 - Sayı: 2

Relationship Between Leptin to Adiponectin Ratio and Metabolic Syndrome Indices in Apparently Healthy Adults

Görünüşte Sağlıklı Olan Erişkinlerde Leptin-Adiponektin Oranı ile Metabolik Sendrom İndeksleri Arasındaki İlişki

Pages
122–131
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: There were significant differences (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Leptin/adiponectin (L/A) ratio is considered a predicting factor of metabolic syndrome (MetS) and its related morbidities.
📊
Key Findings & Data:Material and Methods: This cross-sectional study wasconducted on 150 apparently healthy adults aged 25 to 50 years,who were selected by random sampling from different medicalcenters of Tabriz city, Iran.
💡
Conclusion & Impact:Results: There were significant differences (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Leptin/adiponectin (L/A) ratio is considered a predicting factor of metabolic syndrome (MetS) and its related morbidities. In the present study, we determined the association of serumL/A ratio with MetS parameters in apparently healthy Iranianadults. Material and Methods: This cross-sectional study wasconducted on 150 apparently healthy adults aged 25 to 50 years,who were selected by random sampling from different medicalcenters of Tabriz city, Iran. Our criteria for being a healthy individual were based on self-report of the participants. Anthropometric measures, fasting blood sugar (FBS) and lipid profile, systolicand diastolic blood pressure (SBP and DBP), and fasting serumL/A levels were measured. Results: There were significant differences (p

Özet

Amaç: Leptin/adiponektin (L/A) oranı, metabolik sendrom (MetS) ve bununla ilişkili morbiditeler için öngördürücü bir faktör olarak kabul edilir. Bu çalışmada, görünüşte sağlıklı olan İranlı erişkinlerde serum L/A oranının MetS parametreleri ile ilişkisini inceledik. Gereç ve Yöntemler: Kesitsel tipteki bu çalışma, İran'ın Tebriz şehrindeki farklı tıp merkezlerinden rastgele örnekleme ile seçilen, 25-50 yaşları arasında bulunan ve görünüşte sağlıklı olan 150 erişkin üzerinde gerçekleştirildi. Sağlıklı bir birey olma kriterimiz, katılımcıların kendi beyanlarına dayandırıldı. Antropometrik ölçümler, açlık kan şekeri (AKŞ) ve lipit profili, sistolik ve diyastolik kan basıncı (SKB ve DKB) ve açlık serum L/A düzeyleri ölçüldü. Bulgular: Erkekler ve kadınlar arasında ağırlık, boy, bel çevresi (BÇ), SKB, trigliserit (TG), yüksek-dansiteli lipoprotein-kolesterol (HDL-K), serum leptin konsantrasyonu ve L/A oranı açısından anlamlı farklılıklar (p

🔖

Cite This Article

ESFANJANI, A. T., GHADIMI, S. S., MAMEGHANI, M. E., JAFARABADI, M. A., EHTESHAMI, M., MOLOUDI, J., MALEKI, V., OMIDI, H., VAYGHAN, H. J. (2022). Relationship Between Leptin to Adiponectin Ratio and Metabolic Syndrome Indices in Apparently Healthy Adults. Turkish Journal of Endocrinology and Metabolism, Cilt: 24 - Sayı: 2, 122–131. https://ajindex.com/articles/605361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006
  2. [Crossref] [PubMed] 2. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013
  3. 139239. [Crossref] [PubMed] [PMC] 3. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 2008
  4. [Crossref] [PubMed] [PMC] 4. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010
  5. [Crossref] [PubMed] 5. Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol. 2005
  6. [Crossref] [PubMed] 6. Ackermann D, Jones J, Barona J, Calle MC, Kim JE, LaPia B, Volek JS, McIntosh M, Kalynych C, Najm W, Lerman RH, Fernandez ML. Waist circumference is positively correlated with markers of inflammation and negatively with adiponectin in women with metabolic syndrome. Nutr Res. 2011
  7. [Crossref] [PubMed] 7. Frühbeck G, Catalán V, Rodríguez A, Ramírez B, Becerril S, Salvador J, Portincasa P, Colina I, Gómez-Ambrosi J. Involvement of the leptinadiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017
  8. [Crossref] [PubMed] [PMC] 8. Considine RV. Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. Semin Vasc Med. 2005:15-24. [Crossref] [PubMed] 9. Beltowski J. Leptin and atherosclerosis. Atherosclerosis. 2006
  9. [Crossref] [PubMed] 10.Moran O, Phillip M. Leptin: obesity, diabetes and other peripheral effects--a review. Pediatr Diabetes. 2003
  10. [Crossref] [PubMed] 11. Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep. 2008
  11. [Crossref] [PubMed] 12. Brüll V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Müller C, Langguth P, Alteheld B, Fimmers R, Stehle P, Egert S. No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-) hypertension: a randomized double-blinded, placebo-controlled crossover trial. Eur J Nutr. 2017
  12. [Crossref] [PubMed] 13.